Stay invested in Marksans Pharma, says Ashish Kyal

Ashish Kyal of wavesstrategy.com told CNBC-TV18, "The overall trend in the pharmaceutical space itself, if you look in 2014, there have been the darlings of the entire 2014. We have seen some exceptional rally across the pharmaceutical space. Marksans Pharma also has shown very promising returns in this entire period.""One can definitely hold Marksans Pharma because the long-term trend is intact. Being a cyclical stock there is a possibility that we can also start seeing some kind of consolidation when the other sector start outperforming because pharma has already given tremendous return in one year. So, some consolidation over short to medium-term cannot be ruled out. Once that is over again the uptrend should pick up, so one can definitely stay invested in this stock," he added.